IRIS

Smylie, M., Francis, S., Neyns, B., Maio, M., Minor, D., Verschraegen, C., et al. (2009). Effect of ipilimumab at 10 mg/kg on disease control in patients (pts) with M1c-stage melanoma in relation to baseline lactate dehydrogenase (LDH) levels. JOURNAL OF CLINICAL ONCOLOGY, 27(15).

Effect of ipilimumab at 10 mg/kg on disease control in patients (pts) with M1c-stage melanoma in relation to baseline lactate dehydrogenase (LDH) levels

Maio M;
2009-01-01
2009
Smylie, M., Francis, S., Neyns, B., Maio, M., Minor, D., Verschraegen, C., et al. (2009). Effect of ipilimumab at 10 mg/kg on disease control in patients (pts) with M1c-stage melanoma in relation to baseline lactate dehydrogenase (LDH) levels. JOURNAL OF CLINICAL ONCOLOGY, 27(15).
1.5 Abstract in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1081097